Scinai Immunotherapeutics

community rating (0 votes): 


Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.



No Reviews Yet

Be the first to review one of our webinars!

Upcoming Webinars

Previous Webinars

SCINAI: 2023 In Review and 2024 Plans
CEO Amir Reichman will review Scinai’s 2023 accomplishments and discuss 2024 plans, including bringing Scinai’s anti-IL-17 VHH antibody (‘NanoAb’) innovative psoriasis treatment into clinical trials by the end of 2024.
1/9/2024 3:00 PM